Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins
about
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope GlycoproteinFunctional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay.Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 BindingDiverse CD81 Proteins Support Hepatitis C Virus InfectionA focus reduction neutralization assay for hepatitis C virus neutralizing antibodiesTransmembrane Domains of Hepatitis C Virus Envelope Glycoproteins: Residues Involved in E1E2 Heterodimerization and Involvement of These Domains in Virus EntrySuperinfection Exclusion in Cells Infected with Hepatitis C VirusHepatitis C Virus entry: the early steps in the viral replication cycleMutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entryNovel Function of CD81 in Controlling Hepatitis C Virus ReplicationEndocytic Pathways Used by Andes Virus to Enter Primary Human Lung Endothelial CellsFusogenic properties of the ectodomains of hepatitis C virus envelope proteins.Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.A new model to produce infectious hepatitis C virus without the replication requirement.Self-assembling peptide nanotubes with antiviral activity against hepatitis C virusCharacterization of the envelope glycoproteins associated with infectious hepatitis C virusIdentification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assayHepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry.Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents.Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.Enhanced virus-specific CD8+ T cell responses by Listeria monocytogenes-infected dendritic cells in the context of Tim-3 blockadeScavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation.Hepatitis C virus evasion mechanisms from neutralizing antibodiesThe past, present and future of neutralizing antibodies for hepatitis C virus.Incorporation of hepatitis C virus E1 and E2 glycoproteins: the keystones on a peculiar virion.HCV glycoprotein structures: what to expect from the unexpected.The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain.Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes.Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay.Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans.TNF superfamily members promote hepatitis C virus entry via an NF-κB and myosin light chain kinase dependent pathway.Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.Host mTORC1 signaling regulates andes virus replication.Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder
P2860
Q27470798-93553CEC-3883-4117-8123-D8FD092DC7AEQ27472928-8E519200-A0E2-40F5-A130-05DDCE8BF2AEQ27477468-0753F004-34AC-4D0E-8190-A294DC4E66C1Q27477625-18B89B99-F091-4736-9B8C-4072754D81F6Q27478295-D139F9DA-75FC-4FB4-8B3A-15E63A4C09F3Q27478363-0335C514-195D-4509-BCEF-C6E7CDED0EA8Q27478378-C66C3B52-5B4B-4AD0-96F0-B215F23DF38CQ27489242-4AAC898A-8FCA-49A9-A7FC-65EE574A51BBQ27489898-2B376062-23E0-4929-8A81-0AC25A7280D1Q27491131-F299845D-2A9D-483A-BE59-90B589734AADQ28552959-21EB1D63-1B32-4204-8226-CFEF2B0FEACDQ30360986-3451BEC0-05BD-4CA2-B44E-BEF91597CF85Q30364309-2DFFD5DE-7F38-473C-99D4-D51C05139C04Q33886707-D3AE2912-728D-4A53-A83E-72ACB72F67C2Q34084050-875074B8-83D3-4338-9D44-5C847DC01457Q34120689-4288BB5E-DDDE-433C-A114-28CD813CBD5FQ34403294-05124651-F31F-4F75-811E-AD69293DA25DQ35213305-F6B74A6C-74C2-428E-BE5D-F31B86FDA86DQ36086218-96914DE5-AD9B-4188-858C-71AA891F0B9CQ36956517-A5FDC61F-6AF6-4CA1-AC27-7B61E174CDD1Q37433442-44826892-0997-4E25-9E40-614DD43E8748Q37539241-83488D25-35A5-48F7-B646-5ADF83CFAB83Q37864742-2E07A33F-2D3F-49C3-9090-A779D3E2D599Q37967737-975B82E3-A512-4593-9963-624C75CF5C4EQ38192357-B2338368-A2DC-45F2-97B4-58C88A6A9ECFQ38195180-E24EF5DE-4508-49B5-BBEE-DA829E1204BAQ38384140-AB85B90B-5C35-44C7-B25F-B81206D3FFE9Q38748634-6D3F2CF3-3039-4A19-9737-74EDD9171104Q39532092-53AB000D-9030-4556-9C59-BDA6C4E6C4E9Q39619568-329E4909-B0C3-4796-876F-8733C8F571BDQ40098163-5BBDD768-112A-4AAB-9EEA-AA01A66EED98Q40261250-CF4F4F60-49E9-4E1D-B9F0-D302B1890C85Q40407185-BAB4058A-01A6-46B3-8B14-7AB11C713F10Q40530808-6AF28BAC-C7E7-4A39-B101-06672E4462E7Q42049383-ACBB4A68-7D8F-463D-810B-23848AFC805AQ53683152-E6EB4E0A-AA2B-4FBB-BD38-4F3293243B48Q57265415-348E2BAB-CC21-4EAE-B373-D587BC4B3FDD
P2860
Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Characterization of infectious ...... epatitis C virus glycoproteins
@ast
Characterization of infectious ...... epatitis C virus glycoproteins
@en
Characterization of infectious ...... epatitis C virus glycoproteins
@nl
type
label
Characterization of infectious ...... epatitis C virus glycoproteins
@ast
Characterization of infectious ...... epatitis C virus glycoproteins
@en
Characterization of infectious ...... epatitis C virus glycoproteins
@nl
prefLabel
Characterization of infectious ...... epatitis C virus glycoproteins
@ast
Characterization of infectious ...... epatitis C virus glycoproteins
@en
Characterization of infectious ...... epatitis C virus glycoproteins
@nl
P2093
P2860
P1433
P1476
Characterization of infectious ...... epatitis C virus glycoproteins
@en
P2093
Carine Logvinoff
Charles M Rice
Mike Flint
P2860
P304
P356
10.1128/JVI.78.13.6875-6882.2004
P407
P577
2004-07-01T00:00:00Z